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Abstract: The use of computational modeling and
simulation has increased in many biological fields, but
despite their potential these techniques are only
marginally applied in nutritional sciences. Nevertheless,
recent applications of modeling have been instrumental
in answering important nutritional questions from the
cellular up to the physiological levels. Capturing the
complexity of today’s important nutritional research
questions poses a challenge for modeling to become
truly integrative in the consideration and interpretation
of experimental data at widely differing scales of space
and time. In this review, we discuss a selection of
available modeling approaches and applications relevant
for nutrition. We then put these models into perspective
by categorizing them according to their space and time
domain. Through this categorization process, we iden-
tified a dearth of models that consider processes
occurring between the microscopic and macroscopic
scale. We propose a ‘‘middle-out’’ strategy to develop
the required full-scale, multilevel computational models.
Exhaustive and accurate phenotyping, the use of the
virtual patient concept, and the development of
biomarkers from ‘‘-omics’’ signatures are identified as
key elements of a successful systems biology modeling
approach in nutrition research—one that integrates
physiological mechanisms and data at multiple space
and time scales.
Introduction
Nutritional science is presently undergoing a data explosion as
an increasing number of studies are incorporating methods from
genomics, transcriptomics, proteomics, and metabolomics. How-
ever, it is presently unclear how these high-dimensional datasets
can be related to the physiological characterization of phenotype
using traditional nutritional research methods such as indirect
calorimetry, nutrient balance, body composition assessment, and
isotopic tracer methods. Thus, a fundamental challenge for
nutrition research is to connect these data that are collected at
vastly different spatial, temporal, and dimensionality scales.
Although statistical analysis is still the method of choice to deal
with the high dimensionality of ‘‘-omics’’ datasets, systems biology
and computational modeling approaches begin to reveal quanti-
tative mechanistic relationships between these various measure-
ments.
A large variety of computational modeling approaches have been
applied to wide-ranging levels of organization—from molecules
to humans. The processes that are modeled include molecular
interactions, signalingpathways, metabolicpathways, cellular growth,
anatomical structures, and physiological processes. Accordingly,
computational approaches differ widely with application.
In this review, we discuss the relevance of current and future
applications of computational modeling in nutrition research. To
this end, we first introduce important concepts in nutrition and the
typical issues for modeling that arise in this field. Then, we give a
broader review of some representative modeling approaches that
have successfully addressed key nutritional questions. We then
proceed to identify knowledge and technology gaps and suggest
how the computational approaches may be integrated and
extended to address these gaps and bring nutritional systems
biology modeling an important step forward in the near future.
Nutrition and Modeling
Nutrition research investigates the processes by which the living
organism receives and utilizes the materials necessary for the
maintenance of life and health (as defined by James S. McLester in
his classic 1927 textbook) [1]. Traditionally, nutritional research
investigates these processes at the level of the whole organism.
From a thermodynamic viewpoint, all living organisms exist in a
state that is far from equilibrium. To maintain this state, it is of
central importance to harvest sufficient energy from the
surroundings. This energy comes from the controlled combustion
of the macronutrients carbohydrate, fat, and protein. The
overarching organizing principle expressed in the Dynamic
Energy Budget theory [2], which considers that energy from food
is extracted (by the gut), stored in reserves (body fat, protein, and
carbohydrate pools), and distributed throughout the body to fuel
the processes essential for life. These processes include the
generation of heat, maintenance of gradients across cell mem-
branes, the production of gametes, the synthesis of structural mass,
the establishment of maturity, somatic maintenance, and maturity
maintenance. This organization effectively decouples the organ-
ism’s internal energy from the external world, facilitating
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nutritional physiology.
In contrast to the dietary macronutrient energy sources (i.e.,
protein, carbohydrate, and fat), dietary micronutrients, notably
mineral elements and vitamins, also play a key role for the overall
health of the organism. Inadequate amounts of some dietary
micronutrients have been demonstrated to cause classic deficiency
diseases such as scurvy, beriberi, anemia, goiter, and cretinism. As
a third class, various essential nutrients exist that can be used for
both energy harvesting, synthesis of structural mass, as well as
precursors of specific bioactive compounds. These nutrients
include the essential amino acids and the essential omega-3 and
omega-6 fatty acids.
Many health disorders are not necessarily caused by dietary
deficiencies, but more generally from imbalances between intake
and utilization of nutrients. While there is general consensus that
proper nutrition can prevent various chronic diseases, under-
standing the health effects of specific nutritional compounds is
extraordinarily complicated. First, delivery of a nutritional
perturbation is difficult to control over long time periods and
such perturbations often have relatively subtle effects over the time
scales typically investigated (as compared to pharmacological
compounds whose effects are detected on time scales from minutes
to days or weeks). Second, it is very difficult to unravel the
distinctive bioactivity of a nutritional compound of interest when it
is supplied in a background diet containing hundreds of other
bioactive components. Third, it can be difficult to assess the
bioavailability of the nutrient of interest, especially at the level of
specific target organs or cells.
The problem of bioavailability at the whole body level has had a
long history of mathematical modeling, specifically for trace
elements. Computational kinetic methods were introduced in
nutritional sciences along with the use of stable isotopes where the
interpretation of the kinetic data required the development of
appropriate mathematical models [3–6]. Typically, compartmen-
tal modeling approaches are used to describe the absorption,
distribution, and elimination of a nutrient. Common to most of
these models is the high level of aggregation, where the body is
adequately described by only a few compartments. Together, these
models aim to provide a rational basis for the determination of the
nutritional requirements of the body, and for the understanding of
differences in requirements (both locally for organs and at the
whole body level) for different micronutrients.
While such traditional modeling methods have been very useful, the
real challenge for modeling in nutrition is to help understand and
rationally manipulate the complex relationship between nutrition and
health, which is determined by the integrated multiscale responses to
nutrients, ranging from whole body to subcellular levels of
organization and over time scales of minutes to years.
This difficulty is apparent from the problems that arise with
current efforts to pinpoint the precise role of nutrition in the
metabolic syndrome. At the long time scale and whole body level
of organization, a prolonged period (,weeks to years) of
consuming more energy than is expended results in the gradual
development of obesity and increases one’s risk for developing
insulin resistance—a hallmark of the metabolic syndrome. The
study of insulin resistance has revealed that the function of this
hormone at the level of organs and tissues occurs on the time scale
of minutes to hours. For example, insulin stimulation of skeletal
muscle glucose uptake, inhibition of hepatic glucose output,
inhibition of adipose tissue lipolysis, and a host of other
physiological effects occur on this time scale. Methods developed
to unravel and quantify the molecular mechanisms underlying
these effects have shown the involvement of complex intracellular
signal transduction pathways, changes of gene expression,
modification of enzyme kinetics, and intracellular molecular
trafficking. Furthermore, the production of insulin by pancreatic
beta cells occurs in response to glucose and amino acids and can
be modulated by fatty acids, all of which can clearly be influenced
by diet and nutrition. The unique electrophysiological properties
of beta cells are influenced by the metabolism of glucose and fatty
acids, while the electrical bursting and oscillatory behavior is
coupled to insulin secretion on the time scales of seconds to
minutes. Thus, understanding how nutrition impacts the mecha-
nisms underlying insulin resistance requires a quantitative analysis
and description of a multiscale, highly coupled regulatory network
that includes thousands of components, ranging over subcellular to
whole body levels of organization and spanning time scales from
seconds to years.
Although a conceptual perspective as outlined above can be
derived from literature without too much effort, it is extremely
difficult to develop an integrated quantitative understanding that
spans the entire complexity of the mechanisms involved. In
principle, mathematical models offer this capability and therefore
are required to more fully understand the physiological basis not
only of the metabolic syndrome, but of the role of nutrition in
health and disease in general. Without such a quantitative and
integrative approach, it is inevitable that one will get lost in the
tangle of bubbles and arrows typical of conceptual models and find
oneself unable to weigh the relative importance of each
component or interaction in determining the overall physiological
phenotype.
The field of mathematical modeling in nutrition is very diverse
and presently no single mathematical formalism allows one to
generate the required integrated quantitative understanding of
nutrition as formulated above. Therefore, in developing our vision
of what is needed in the coming years, we now review several
representative models that have successfully addressed key
nutritional questions and together may help point the way to a
more integrative modeling approach.
First, we review modeling approaches for processes at the
cellular level describing the biochemical processes (i.e., signaling-
and metabolic pathways) that operate to convert food ingredients
into energy and building blocks for the cell as the fundamental unit
of life. Insight into these processes teaches us how metabolism is
regulated at its most basic level. Furthermore, modeling at the
cellular level provides the entry point to considering the vast
quantity and complexity of ‘‘-omics’’ data.
Second, we review the use of metabolic flux analysis (MFA) as a
framework for the quantitative analysis of material fluxes within the
single cell as well as between different cell populations and organs,
up to the whole body level. Thus, MFA forms a natural bridge
between different levels of organization and different time scales.
Thirdly, we review compartmental models of lipoprotein
metabolism, because lipoproteins are the major mediators of lipid
trafficking between organs, and many processes linked with lipids
are associated with the metabolic syndrome, which includes
cardiovascular diseases, obesity, and insulin resistance, modern
plagues in industrialized societies. Finally, we review mathematical
models of body weight and composition regulation and the
complex relationship with macronutrient metabolism at the whole
body level. Modeling at this whole body physiological level
demonstrates the importance of considering long time scales that
are characteristic of chronic diseases like obesity and metabolic
syndrome.
Of course, we cannot cover all areas of modeling in the field of
nutrition in this review. For instance, we will not review models of
gut-associated processes of nutrient absorption and bacterial
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compounds as short-chain fatty acids (for a review on the latter, see
reference [7]). Another important area that we will not review is
models of the neuro-hormonal regulation of food intake and
metabolism. Nevertheless, the collection of models that we chose
to review ensures that we cover process occurring on a vast space–
time spectrum, from nanometer to meter and from microseconds
to years. Therefore, the four areas of modeling that we discuss
provide a sufficiently broad basis for our goal, namely to review
the available computational approaches that are key to answering
central questions in nutrition and that can serve as a platform for
the development of more integrative systems models.
Cellular Modeling Approaches
Mathematical models of cellular processes can be used to
simulate cellular behavior to better understand the complex
mechanisms underlying experimental observations. This under-
standing may relate to specific research questions such as how the
system will react to the addition of a certain substrate (nutrient) or
the deletion of a gene. Alternatively, cellular models may also
address more general issues such as how control is distributed in a
complex network. Predictions can subsequently be experimentally
tested, and observed deviations from model predictions can help
with data interpretation through the process of modifying the
model to better represent the true behavior of the cell [8].
To allow such quantitative simulation and prediction, cellular
modeling ultimately aims at a detailed, mechanistic description of
molecular processes occurring in single cells. Towards this goal,
known pathway structures are translated into differential equations,
which—after estimation of the unknown parameters from exper-
imental data—can be used for dynamic simulations of a pathway or
network behavior. However, such mechanistic modeling approach-
es are presently only feasible for rather small pathways or networks.
Thus, even on the cellular level, there is a gap between kinetic
mechanistic models on the one hand and more coarse-grained
modeling approaches on the other hand. The latter are larger in
scope (i.e., they encompass more modeled components and
interactions—up to the genome scale) but describe the interactions
between the modeled components with less mechanistic detail. This
section provides an overview of the two categories of mathematical
modeling approaches that are used to describe processes on a single
cell level and mentions application areas.
Mechanistically detailed kinetic models. The first type of
cellular models describe molecular mechanisms at the cellular level
on the basis of ordinary differential equations. These models
consist of balance equations describing the dynamic concentration
changes of the considered molecules with appropriate rate laws
(e.g., mass action or Michaelis-Menten kinetics). In most cases,
these models consider only a few dozens of molecules and either
focus on metabolic or on signaling processes. Prominent examples
of such models include a model of glucose metabolism of the red
blood cell [9], and a model for the yeast Saccharomyces cerevisiae that
mechanistically describes the organism’s response to osmotic shock
[10]. The latter describes biochemical reactions comprising
receptor stimulation, mitogen-activated protein kinase cascade
dynamics, gene expression activation, and adaptation of cellular
metabolism with a thermodynamic description of volume
regulation and osmotic pressure. As such, this model is one of
the few kinetic models that describe processes on more than one
cellular level. A recent model of the carbon transfers in the hepatic
folate cycle [11] is an example of a model directly related to a
specific nutrient. More cellular models can be found in dedicated
model repositories (www.systems-biology.org, www.biomodels.
org).
From such kinetic models, mechanistic insight about the
modeled molecular interactions can be obtained by means of
numerical simulation and other computational analyses such as
metabolic control analysis, which determines how the control of
flux is distributed in metabolic networks [12]. One of the major
hurdles in the development of these mechanistic models is that
significant uncertainties exist in the molecular mechanisms and in
the respective model parameter values. Typically, such informa-
tion is estimated from either kinetic measurements in an isolated in
vitro system, or from parameter optimization methods to fit the
model to quantitative (and ideally dynamic) measurement data
obtained from the in vivo system. Although currently such data are
being generated for single cell organisms, model structure and
parameter identification challenges remain huge, particularly with
models of larger size [13].
Large scale, coarse-grained topological network models.
The second type of mathematical models are coarse-grained
topological network models. These models—denoting static
representations of components (nodes) and interactions (links)—
describe the interactions between molecular components with less
molecular detail than kinetic mechanistic models (and sometimes
without any detail), but often include hundreds to thousands of
components, up to the full genome scale. The capability to create
such models arose in parallel with the capability to sequence and
annotate genomes and the advent of high-throughput ‘‘-omics’’
techniques. These models basically represent an organism-specific
collection of components and interactions based upon, for example,
the genome annotation and on information from the literature. As
such, topological models can be first considered as comprehensive
collections of the information about a particular network (i.e.,
components and interactions) within a specific organism. Well-
known examples for such topological models are the signaling
networks of the epidermal growth factor receptor [14] and the Toll-
like receptor [15] or the recently published complete metabolic
network of the human cell [16]. The complexity of these models can
even be further expanded by including component interaction,
physical arrangement, and evolutionary changes as separate
additional dimensions [17].
A special class of topological models, stoichiometric metabolic
network models, describes an organism’s complete set of metabolic
reactions. Typically, stoichiometric models describe the chemical
stoichiometries of the biochemical reactions of an organism in its
entirety to predict the steady state fluxes of all pathways in the
network given the uptake rates of one or more substrates (e.g.,
nutrients). Such models have been developed for many organisms,
including yeast [18], mouse [19], and human [16,20].
Utility of cellular models. Mechanistically detailed kinetic
models allow one to numerically simulate the behavior of a small
part of the cellular system in response to changes of environmental
parameters(e.g.,modelinputs)orwhenspecificcellularcomponents
are modified (e.g., gene knock-outs). Coarse-grained topological
network models can be used for qualitative simulations, even at the
basic level of curated knowledge. For example, assuming that
individual regulatory interactions are either on or off generates a
kind of discrete network dynamics much the same as in logical
electronic circuits, hence they are referred to as Boolean network
models [21]. Surprisingly (because no mechanistic detail was
included), patterns in the regulatory properties of such networks
often match those found experimentally in the modeled biological
system.
Current research tries to uncover and exploit pattern structures
in the interactions that make up the topological model so as to
infer specific regulatory properties of the network. For instance,
metabolic reactions from the recently reconstructed human
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bow-tie structure (one that makes a network flexible and robust at
the same time [22]) depending on whether or not they are fuelled
by essential nutrients [16]. As another example, since metabolic
networks appear to be organized in a modular and hierarchical
manner, methods for rational decomposition of the metabolic
network into relatively independent functional subsets can help us
better understand the modularity and organization principle of
large-scale, genome-wide networks [23].
Secondly, graphical representations of topological network
models may be used to map results of transcriptomics, metabo-
lomics, or proteomic experiments that compare cellular behavior
under different conditions. As such, these models allow for a more
or less direct linkage between wet lab and model at the -omics
level. For instance, representing increased/decreased concentra-
tions in a network context often allows one to efficiently locate by
visual inspection the spots in the respective network where most of
the changes occurred. Recently, a graph-based algorithm has been
proposed that allows one to computationally map transcript data
onto a genome-scale metabolic network model. This approach
identifies so-called reporter metabolites (i.e., metabolites around
which the most significant transcriptional changes occur) from
gene expression data as demonstrated by a study on different
carbon sources and/or genetic perturbations in yeast [24]. In
another approach, a stoichiometric metabolic network model was
used to predict putative active regulatory sites in metabolism on
the basis of quantitative metabolome data and a thermodynamics-
based computational approach [25,26].
Finally, the concept of constraint-based modeling [27] (an
example of which is flux balance analysis) was developed to
perform computational simulations with stoichiometric metabolic
network models. Such simulations are based on a numerical
optimization of a certain biological objective (e.g., biomass yield)
within the constraints defined by the steady-state mass balance
equations describing the reaction stoichiometry along with energy
[28], thermodynamic [25,26], or physico-chemical considerations
[29]. Within certain limits, constraint-based models can predict
the effect of metabolic gene deletions on the fitness of a cell and the
modulation of phenotypes in response to substrate (i.e., nutrient)
availability can be studied in silico and verified experimentally.
Towards closing the gap between the two cellular
modeling approaches. The future challenge for modeling
processes on the cellular level will be to describe larger networks in
a mechanistic way. For example, ideally we would like to predict
the effects of simultaneous application of a nutrient with a drug
such that the best cellular marker for a given response (e.g.,
hepatocyte insulin response) can be identified. To meet this
challenge, models are required that integrate the kinetic as well as
the topological approaches. Such models should first be calibrated
using experimental flux and ‘‘omics’’ data taken from a set of
individuals with well-chosen biological variability (i.e., genetic
difference), then used for prediction. On a small-scale, this
integrative approach was demonstrated to work for lysine
production in Corynebacterium glutamicum [30], where various genes
were deleted or overexpressed and their effects were correctly
predicted. It may also be feasible to construct large-scale
mechanistic models by combining mechanistically detailed
kinetic models and coarse-grained topological network models
[31]. In fact, it was recently shown that complex system behavior is
often largely defined by the model structure (i.e., the interaction
topology) [32,33]. This finding further supports the expectation
that in order to obtain meaningful predictions most likely only a
few molecular processes need to be described in great detail
with precise parameters estimates, while the rest of the system can
be described using the coarse-grained interaction topology.
Therefore, since genome-scale topological network models are
now available from microbe to man and high-throughput
experimental data are becoming more and more available, it is
possible that genome-scale kinetic models can be built in the not-
too-distant future [34]. Thus, we foresee that the activities in the
field of cellular modeling will eventually lead to a situation where
in silico prediction of the effects of nutritional and
pharmacological treatments in health and disease will be part of
the biological research routine [8].
MFA
Flux balance analysis is closely linked to an experimental
technique called MFA, which allows one to quantify intracellular
metabolic fluxes on the basis of acquired experimental data on the
uptake and/or production rates of a few metabolites. Stoichio-
metric metabolic network models, as discussed above in Cellular
Modeling Approaches, provide the basic modeling background for
MFA [35].
The power of MFA can been significantly augmented by also
including experimental data from stable isotope labeling experi-
ments [36]. Metabolic networks are thereby probed with complex
mixtures of multiply stable isotope-labeled precursors, and the
data analysis proceeds via isotopomer distribution modeling,
which is again built around stoichiometric mass balance (or,
rather, isotopomer balance) equations [37–39]. Stable isotope-
aided MFA has found broad application in metabolic engineering
efforts aimed at the targeted improvement of microbial fermen-
tations [38]. MFA is increasingly being used in biomedical studies,
especially since some investigators have argued that metabolic
pathways, rather than genes or proteins, are the true units of
function in biology and biochemistry [40]. Thus, flux analysis of
target proteins and amino acids in lipoproteins, or of isotope-
labeled target compounds in lipoproteins such as glycerol, may
help elucidate the mechanisms by which components in the diet
(especially dietary fatty acids) affect lipoprotein metabolism and
thereby influence the risk of cardiovascular disease (see Modeling
of Lipid Transport, below). Furthermore, intrahepatic flux analysis
of triglycerides, glycerol, and fatty acids may help elucidate the
mechanisms by which components in the diet affect development
of hepatic steatosis and subsequent changes in lipoprotein
metabolism, which are major contributors to the development of
insulin resistance.
Because metabolic fluxes are closely associated with the
physiological phenotype, whereas genome-wide stoichiometric
models provide the basis for their modeling, MFA bridges the
gap between genotype and phenotype, and provides a key for
integration of the modeling levels. Indeed, MFA has become a key
technique to advance the understanding of biochemical control
and gene function. Mapping the effects of gene overexpression and
deletion onto changes in intracellular metabolic fluxes, has often
revealed unexpected compensatory regulation mechanisms that
result in an absence of any clear phenotype. Alternatively, such
analyses can help explain an unexpected phenotype. The series of
MFA studies on amino acid overproduction by the bacterium
Corynebacterium glutamicum (reviewed in [41]) provides a number of
interesting examples that illustrate this point. One particularly
interesting case shows how this organism adapts to growth on
acetate instead of glucose. Not only does it activate the classical
acetate-induced glyoxylate pathway, but it also greatly increases
the amount of oxaloacetate that is decarboxylated to (phosphoe-
nol) pyruvate thereby creating the required acetyl-coenzyme A
needed as energy substrate for the citric acid cycle. In mammalian
systems, modern genetic techniques can generate highly selective
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which has led to a variety of mouse models with interesting
metabolic phenotypes. MFA of these mouse models promises to
help elucidate mechanisms of metabolic regulation in both health
and disease.
Modeling of Lipid Transport
Modeling can help to explain the mechanisms involved in the
dyslipidemia that occurs with type 2 diabetes, obesity, and the
metabolic syndrome. Lipids are a major source of energy and are
essential for many processes in the cell, including signaling. Lipids
are stored and transported as nonpolar, inert triglycerides.
However, neutral lipids are hydrophobic and need to be packed
into hydrophilic particles, called lipoproteins, in order to be
transported in the blood or into lipid droplets to be stored inside
the cell. Lipids are safely stored inside adipocytes in the adipose
tissue, however when the lipid load exceeds the adipose tissue
storage capacity, lipids are instead stored in other organs resulting
in ectopic lipid distribution. These organs, such as liver, heart,
pancreas, and muscle are apparently suboptimally equipped to
store lipids, and insulin resistance develops. This is obvious in
patients with lipidystrophy, who lack adipose tissue and develop
severe insulin resistance as well as other symptoms normally
associated with obesity [42].
The liver plays a central role in lipid metabolism as it
redistributes dietary, systemic (released from adipose tissue), and
de novo synthesized lipids into very low density lipoproteins
(VLDLs), the precursor for low density lipoproteins (LDLs). In
humans, LDL is the major cholesterol carrier in the blood. Under
atherogenic conditions it can enter the arterial wall and cause
atherosclerosis. The associated dysregulation of lipoprotein
metabolism leads to dyslipidemia, which is typically observed in
type 2 diabetes, obesity, and the metabolic syndrome [43],
explaining why VLDL and LDL have been intensively studied.
The lipoproteins consist of a core of nonpolar lipids, such as
triglycerides and cholesterol esters, surrounded by an amphi-
pathic monolayer of phospholipids and free cholesterol. On the
surface different proteins (apolipoproteins) are attached, hence the
name lipoproteins. Traditionally, the lipoproteins are divided into
different classes depending on their protein content and their
density, measured by ultracentrifugation. In general, a large particle
has a higher lipid to protein content and thus has a lower density.
The metabolism of the apolipoprotein B100 (apoB100) carrying
lipoproteins (VLDL, intermediate density lipoprotein [IDL], and
LDL) is briefly outlined in Figure 1A. The kinetic properties of a
lipoprotein particle depend on the composition of the different
apolipoproteins, the size, and most likely other factors such as the
composition of the surface phospholipids. For instance, triglycer-
ides in VLDL are hydrolyzed by lipoprotein lipase, which in turn
is activated by apolipoprotein CII on the surface but inhibited by
apolipoprotein CIII.
Current models of in vivo lipoprotein metabolism provide
lipolytic rates. Today, lipoprotein kinetics are studied using
infusion of stable isotope-labeled amino acids and glycerol [44,45].
The enrichment of the stable isotopes is measured for time periods
of 8 h up to 5 d in different lipoprotein classes separated by
ultracentrifugation.
The main choice of mathematical model to analyze the resulting
data has for the past few decades been multicompartmental
modeling. Generally these models consist of blocks as described in
Figure 1B. A block may contain several compartments, each of
which represents material with homogenous kinetics, often
corresponding to a separated density fraction of lipoproteins.
Recently a model was published where stable isotopes of leucine
and glycerol are used as tracers, and VLDL1 and VLDL2 are
modeled in a combined model [46]. In this model each
compartment in the VLDL blocks (Figure 1B) corresponds to a
specific triglyceride:apoB100 ratio (triglycerides per particle) and is
represented by one apoB100 compartment and one triglyceride
compartment. The equation for the rate of change of an apoB100
compartment is thus linked to the rate of change of the
corresponding triglyceride compartment size. This procedure of
tying together the apoB100 and triglyceride models enhances the
precision of the model as a whole. As each particle contains one
single copy of apoB100, the model provides an estimate of the
lipolytic rates (the loss of triglycerides per time unit), which can
Figure 1. Lipid transport in the body: modeling of apoB100-containing lipoproteins. (A) apoB100 carrying lipoproteins are synthesized in
the liver by stepwise addition of lipids to the growing particle. Once secreted, lipoprotein lipase (LpL) and hepatic lipase (HL) may hydrolyze the
triglycerides. Intermediate- and low-density lipoproteins (IDLs and LDLs) may be taken up by the LDL receptor. (B) The outline of compartmental
models describing lipoprotein kinetics consists of subsystems of tracer molecules (e.g., leucine and/or glycerol), which can be replaced by forcing
functions from sample data. A time delay represents the incorporation of the tracer molecules into proteins and triglycerides and is modeled as a
series of compartments. The complexity of the blocks representing VLDL1, VLDL2 (and IDL and LDL) varies with the studied individuals, the length of
the study, and the infusion (bolus or primed constant).
doi:10.1371/journal.pcbi.1000554.g001
PLoS Computational Biology | www.ploscompbiol.org 5 November 2009 | Volume 5 | Issue 11 | e1000554then be used as a physiological readout for answering study
questions related to dyslipidemia.
Novel modeling approaches help to link up with
molecular mechanisms. There are also new, mechanistically
driven approaches emerging in cholesterol modeling. A particle-
centered model approach has been described independently by
Hu ¨bner [47] and by van Schalkwijk [48]. They showed that
cholesterol plasma levels can be simulated as resulting from a
steady state of a particle distribution. Formulated as a stochastic
particle population model, a large number of individual
lipoprotein particles must be modeled for a simulation, and
considerable computational power is required. Alternatively, as in
[48] a large number of lipoprotein compartments similar to the
ones figuring in traditional lipoprotein models (see above) may be
defined and simulated, thereby greatly improving the
computational efficiency. Pearson and coworkers [49] have
published a deterministic model for lipoprotein endocytosis in
which different processes for the uptake of LDL and VLDL
particles and the receptor kinetics are integrated in a model and
compared to in vitro data. These model approaches are still in
early development, but show that there is a progress in integrating
molecular information in the field of lipoprotein/cholesterol
modeling, further helping to tie down phenomenological/
physiological observations to underlying molecular mechanisms.
What can we learn about normal and patho-physiology
from models of lipoprotein metabolism? As shown, stable
isotope studies and mathematical modeling provide a tool for the
in vivo probing of lipoprotein kinetics and help to reveal
mechanisms involved in dyslipidemia observed in various disease
states. Results from recent kinetic studies in individuals with the
metabolic syndrome have been reviewed recently [50,51]. These
and other results testify that models have played a key role in
elucidating the regulation of secretion of the differently sized
lipoproteins. For instance using the above model it was shown that
type 2 diabetes patients oversecrete the largest VLDL1 particles
whereas VLDL2 production is comparable [51] adding to the
knowledge that VLDL is oversecreted in obesity and type 2
diabetes [52,53]. Moreover, the approach allowed pinpointing
liver fat as the best determinant of VLDL1 production [54] and of
the dynamic response to insulin [55].
What is the lipid-lowering mechanism of statins/omega-
3/weight loss? By quantifying lipoprotein metabolism in treated
and nontreated individuals, the effect of interventions on lipid
metabolism can be studied. Both weight loss and omega-3
treatment have thus been shown to act on lowering plasma
lipids by decreasing the secretion [56–59], whereas an increased
clearance rate was found to be the resultant of the lipid-lowering
drugs statins [60].
To elucidate further details of the molecular processes involved
in lipid metabolism, in vitro studies are required. The information
gained in these molecular studies can serve as scaffolds for models
that can then be tested in vivo using the appropriate experimental
labeling techniques, analysis protocols, and mathematical models.
Clearly, in vivo studies, in combination with mathematical
modeling, are essential to provide information regarding both
normal physiology, dys-regulation in disease states, and mecha-
nistic insights of drug effects, because this cannot be learned from
molecular studies in vitro.
Modeling Whole Body Metabolism and Body Weight
Change
Understanding the dynamics of human body weight change has
important consequences for nutrition-related conditions such as
obesity, starvation, and wasting syndromes such as anorexia
nervosa and cancer cachexia. But making quantitative predictions
of body weight and composition changes has proved difficult
because of the number of interacting components and the inherent
nonlinearity of the system. However several recent mathematical
models have substantially improved our ability to integrate whole
body metabolism data with body composition data and make
quantitative predictions as reviewed below.
What proportion of weight loss is attributable to reduced
body fat? Ideally, weight loss interventions would primarily result
in body fat loss, but unfortunately lean tissue mass is also reduced.
A recent mathematical model was developed to quantify the
factors that determine the proportion of weight loss coming from
body fat versus lean tissue. The basis for the model was a classic
theory of Gilbert Forbes who hypothesized that longitudinal body
composition changes are described by movement along a
logarithmic curve relating lean body mass to fat mass [61]. The
new updated equation accounted for the effects of the initial body
fat mass as well as the direction and magnitude of weight change
as depicted in Figure 2 showing the proportion of weight loss from
body fat mass as a function of initial fat mass for different degrees
of weight loss [62].
The predictions of the new equation compared favorably with
data from human under-feeding and over-feeding experiments
and accounted for previously unexplained trends in the data. For
large weight changes, such as the massive weight losses found in
obese patients following bariatric surgery, Forbes’s original
equation consistently underestimated the lean tissue loss—a
potentially dangerous result. Because the new equation accounted
for the magnitude of the weight loss, it provided better predictions
of the body composition changes observed in bariatric surgery
patients.
What is the required energy deficit per unit weight
loss? Weight loss is caused by eating fewer calories than are
expended to perform physical work and maintain life. But how
many calories translate to one kg of body weight change and what
are the biological determinants of this calorie-to-weight loss
conversion? The ubiquitous dieting rule ‘‘3,500 kcal to lose one
pound ’’ has been used for more than half a century to estimate
expected weight loss. Despite its popularity, the biological basis of
this rule has been mysterious. A recent mathematical model
showed that the caloric equivalent of lost weight is not a constant
but rather depends nonlinearly on initial body fat mass, with fatter
Figure 2. The proportion of body weight loss (DBW) from loss
of body fat mass (DFM) as a function of initial fat mass (FM) for
different degrees of weight loss DBW as calculated using a
novel mathematical model [62] that revisits Forbes classical
theory [61].
doi:10.1371/journal.pcbi.1000554.g002
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same amount of weight loss [63]. The magnitude of weight loss
also plays a role in determining the caloric equivalent of lost
weight and the popular dieting rule was found to be approximately
valid only for obese people with initial body fat above 30 kg.
What permanent lifestyle changes are required for
weight-loss maintenance? Diet and exercise can successfully
cause significant weight loss in obese individuals, but most people
eventually regain their lost weight. Weight regain is likely due to a
return to the former lifestyle and it is unclear what permanent
changes would be required to maintain lost weight. In other
words, if an obese person wishes to achieve a specified goal weight
then how would their diet or physical activity have to permanently
change to maintain their goal weight? A quantitative answer to this
question at the outset of an obesity intervention could help both
the patient and physician assess whether long-term adherence to
the calculated lifestyle change is a realistic proposition. Before a
recent mathematical model was developed to address this
important topic, such a calculation was not possible.
The mathematical model accounted for the decreased energy
requirements at a reduced body weight and incorporates the
nonlinear relationship between body fat and lean mass changes
[64]. The model calculated the expected change of steady-state body
weight loss arising from given changes of dietary energy intake and
physical activity. Conversely, the model equations were also solved
for the energy intake change required to maintain a particular body
weight loss. The model was developed using data from eight
longitudinal weight loss studies representing 157 participants with
initial body weights ranging from 68–160 kg and stable weight
changes between 27a n d254 kg. The model provided the first
realistic calculations of body weight and composition change as well
as the dietary modifications required for weight loss maintenance.
Importantly, the model was implemented using standard spreadsheet
software and can therefore be widely used by physicians and weight
management professionals [64].
Can weight loss interventions specifically target ‘‘belly
fat’’? The anatomical location of body fat storage is another
important issue of body composition. A common question is
whether there are ways to target the reduction of fat in specific
areas of the body. In particular, it would be desirable to target
visceral adipose tissue, commonly called ‘‘belly fat,’’ since fat
storage in this area is believed to confer greater risk of cardio-
metabolic disease. But what determines the relative change of fat
storage in some locations compared with others? Is it possible to
‘‘spot reduce’’ belly fat with certain diet or exercise programs?
A large number of clinical studies have investigated whether diet
interventions, exercise, or bariatric surgery can preferentially
target the reduction of belly fat, with some investigators
concluding that exercise specifically targets visceral adipose tissue.
However, a recent mathematical modeling analysis of these data
found that changes of visceral adipose tissue do not depend on the
type of weight loss intervention. Rather, the model showed that a
simple allometric equation with a single parameter explained more
than 70% of the variability of the data relating the changes of
visceral adipose tissue to changes of overall body fat [65]. The
model showed that changes of visceral adipose tissue are primarily
determined by overall body fat changes as well as the initial ratio
of visceral to total body fat—a variable that also accounted for the
influence of sex. The model also correctly predicted how
increasing weight loss decreases the proportion of fat loss from
visceral versus subcutaneous tissue [66]. The simple allometric
equation has clinical utility because it can be used as the
appropriate null hypothesis to test whether an intervention
specifically targets the reduction of visceral adipose tissue.
How does the body decide what fuel mixture to
burn? The food we eat has three macronutrients that the
body can use to provide energy: carbohydrate, fat, and protein.
But how does the body decide what fuel mixture to use? The
composition of our diet clearly plays a strong role, but does our
body composition also provide feedback that influences fuel
selection? How does fuel selection change during under-feeding or
over-feeding?
A two-dimensional ordinary differential equation model of
human macronutrient balance was recently developed where the
dynamics of the model were constrained to obey the Forbes
logarithmic body composition curve [67]. This procedure resulted
in a single equation that, for the first time, explained how
interactions of diet, energy expenditure, and fat oxidation are
quantitatively connected to changes of body composition [68].
Remarkably, the equation (containing no free parameters)
accurately predicted the observed changes of body composition
and fuel selection during both experimental under- and over-
feeding in adult humans when the measured food intake and total
energy expenditure were provided as inputs to the model. A
similar approach was also used to calculate fuel selection during
normal human infant growth and provided the first dynamic
picture of how metabolism adapts in concert with changes of diet
and energy expenditure to give rise to normal tissue deposition
over the first 2 y of life [69].
To better understand the complex interactions among meta-
bolic fluxes contributing to whole body fuel selection, a detailed
computational model of human macronutrient metabolism was
developed [70]. The model quantitatively tracks the metabolism of
all three dietary macronutrients and their interactions within the
human body. In particular, the model describes how diet
perturbations result in adaptations of whole body energy
expenditure, fuel selection, and various metabolic fluxes (e.g.,
lipolysis, lipogenesis, gluconeogenesis, ketogenesis, protein turn-
over, etc.) that ultimately give rise to changes of body weight and
composition on a time scale of days to years. The nonlinear
differential equation model was developed using published human
data from over 50 experimental studies and has been subsequently
validated using a wide variety of clinical data where the food
intake was controlled, including studies of over-feeding, under-
feeding, and isocaloric exchange of dietary macronutrients in lean
and obese men and women.
The computational model was designed with the specific goal of
helping to design, predict, and analyze the results of prospective
clinical studies and has been used to identify knowledge gaps and
thereby design a novel clinical research protocol currently
enrolling participants at the National Institutes of Health (NIH)
Clinical Center (ClinicalTrials.gov identifier NCT00846040).
Model simulations were instrumental for the design of the clinical
protocol to address questions about the length of time required to
detect a significant effect during the controlled diet intervention as
well as the required magnitude of the intervention and expected
sensitivity to interindividual participant differences and uncertain-
ties in measured parameters.
What is the cause of involuntary weight loss in patients
with advanced cancer? Often, patients with advanced cancer
experience debilitating involuntary weight loss. This wasting
condition, called cancer cachexia, is associated with a variety of
metabolic changes that affect macronutrient and energy balance.
A computational model of macronutrient balance was recently
used to integrate the available data on the metabolic changes in
patients with cancer cachexia. The resulting computer simulations
showed how the known metabolic derangements (e.g., increased
proteolysis, lipolysis, and gluconeogenesis) synergize with reduced
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mass, and lean tissue [71]. The model was also used to quantify the
contribution of hepatomegaly to the elevated metabolic rate
observed in patients with advanced colon cancer [72]. The
computational model also provides a new tool to help predict the
effects of potential therapies. The model showed that the recently
suggested therapeutic approach of lipolysis inhibition could be
detrimental to cachexic patients because the simulations predicted
that fat preservation comes at the expense of further deterioration
of lean body mass due to increased reliance on body protein for
oxidation and gluconeogenesis. Importantly, the model helps
elucidate the mechanisms of body weight change in this complex
and serious disorder where it would be prohibitively difficult and
invasive to attempt a comprehensive clinical study.
Discussion
Here we will put the available modeling approaches into
perspective and work towards an approach for fully integrated
systems biology modeling applications in nutritional sciences.
Classification according to space–time scales. Classi-
fication and dimensions play a crucial role in comparing and
assessing the different model approaches. An excellent introduction
on different levels of mathematical modeling, especially on
multiscale modeling in biology, by Southern et al. [73] addresses
this point. In their publication, the authors divide the model
universe into 11 categories, according to levels of biological
organization. These range from the smallest scale at the quantum
level to the largest scale at the environment level.
Following this classification scheme, the nutritional models
discussed in this review span seven levels, from macromolecular to
organism. Armed with such a hierarchical view, one can also
distinguish between single level models, which are confined to one
level of organization, and multilevel models that span two or more
levels. In fact, to date, there are only a few examples of multilevel
models in biology. The most famous is the Virtual Heart,
developed by a large consortium formed along the Physiome
Project [74,75]. Another example is provided by the PhysioLab
platforms developed by Entelos to predict the efficacy and safety of
therapeutic interventions in areas such as metabolism, rheumatoid
arthritis, and atherosclerosis [76,77]. To visualize their level and
range, and for discussion purposes, we have positioned in Figure 3
an Entelos-type multilevel model together with the model
approaches presented in this review in a quantitative context. In
addition to the space dimension given by Southern, we also added
the time scale dimension of the models, as some approaches at the
same organizational level differ significantly with respect to their
characteristic time scale. Clearly, the Entelos model approach is
the most advanced multilevel approach among the given models.
It can also be appreciated from Figure 3 how far a signal
transduction model is removed from a whole body model. This
does not mean that a connection is a priori impossible, but simply
that in order to link these two models one has to bridge numerous
levels of time and space.
At this point we can ask the question, what class of models
should a nutritional scientist choose for her/his research? It is clear
that there is no right or wrong answer to this question, but each
modeling project should be designed fit the research questions it
should help to answer. Thus, a model constrained to a single level
is best suited to quickly integrate experimental data of that same
dimension. This helps to initiate and stimulate a collaboration
between wet lab and dry lab researchers, because results of such a
model can provide rapid feedback and develop new insights that
will lead to improved experimental designs. The models of
metabolism and body composition change discussed in this paper
are very good examples. Interestingly, these minimally parame-
terized models can predict endpoints of body composition and
energy metabolism reasonably well on time scales ranging from
days to years. An important conclusion from this observation is
that these models may provide ideal constraints and a framework
to embed smaller functional units. Working single level models can
be established in a matter of weeks as far as the basic equations are
concerned, but the careful parameterization and validation require
considerably more time and effort.
The modeling of cholesterol (models 3 and 4 in Figure 3)
provides examples for an approach that could be coined as
‘‘middle out’’ approach, where modeling is started from a single,
intermediate level and the model is subsequently extended
upwards to include more physiological constraints or downwards
to integrate molecular processes. Often, such an approach can be
helpful to integrate new experimental data within an existing
single level modeling framework.
Multilevel models are the most resource-intensive models and
will require a high level of ambition. As an example, the
PhysioLab platforms developed by Entelos are designed to
reproduce clinical observations in humans, based on detailed
mechanistic descriptions of processes from the cellular to the
organism level. Rather than attempting to include all aspects of
physiology, or all intracellular events, the design process identifies
the key biological processes and molecular players that are
necessary to answer the clinically relevant questions. Data are
gathered from the literature to quantitatively describe these
Figure 3. Overview of the time–space range of the diverse model types, which are discussed in this review.
doi:10.1371/journal.pcbi.1000554.g003
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solved numerically as a function of time. After calibrating the
model at various levels to be consistent with known in vitro and
physiological data, the final model predictions are validated
against clinical trial results for several existing therapies. While
these modeling platforms are developed for commercial purposes
in the field of pharmaceutical research and development, the
approach may also be suitable for a range of multilevel problems
in nutritional science and is likely better suited to producing
physiologically meaningful results than direct attempts to extend
detailed models at the signaling level ‘‘upward’’ to the multicellular
context.
A lack of overlap between existing models at different
space–time scales is a hurdle for the integration of existing
models. There are several areas in nutritional research (e.g.,
metabolic syndrome, weight management, or degenerative
diseases) that provide interesting candidates for building
multiscale models. To illustrate the issues involved, we return to
the example of insulin resistance as a central issue in nutrition-
related disease. In Figure 4A, we have tried to construct an
example of a multiscale model for the disease process of insulin
resistance by using existing models. On the top level, the organism
level, a body weight dynamics model [61,78] accounts for overall
energy and macronutrient balance of the body. This model has
been calibrated using data from controlled diet studies that
measured energy expenditure, respiratory quotient, oxidation rates
of fat, protein, and carbohydrates in conjunction with body weight
and composition changes. On a lower level, an insulin-glucose
model links changes in glucose and insulin levels. Such a model
(e.g., the ‘‘minimal model’’ of glucose metabolism [79]) uses
plasma data from glucose tolerance tests or glucose-insulin clamps.
This model is coupled with the top level model via the
carbohydrate energy flows. At the lowest level, a subcellular
model of the insulin signaling pathway [80] simulates the response
of pathways affecting glucose, protein, and fat metabolism
resulting from changing insulin concentrations. Signaling
pathway models are typically calibrated using data from in vitro
cell systems and in vitro enzyme kinetics. Such a multilevel model
would be able to connect insulin action at a cellular level with
insulin sensitivity represented by the minimal model and resulting
in shifts of whole body energy metabolism and body composition.
However, analyzing this model in the time–space plot
(Figure 4B), one can see a large gap between models 2 and 3
representing the gap between physiological modeling and cellular
Figure 4. Example of a future multiscale model in the area of insulin resistance, built from three existing models [78–80]. (A)
schematic overview of the different model layers. (B) Individual model layers plotted along their time–space dimensions. Model 4 denotes a new
model that enables the incorporation of tissue-specific gene expression data, which form an important data source from the nutritional wet lab.
doi:10.1371/journal.pcbi.1000554.g004
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nutrition: knowledge and models with a high level of detail at the
cellular level, a physiological model spanning the levels of organ to
whole body that include the main regulatory mechanisms, and a
picture of general trends in resulting phenotypes that have been
obtained from nutritional intervention studies and/or statistical
population analyses. What is missing is a middle-out model from
the micrometer to centimeter range, which covers processes
between cells, and within and between tissues on a time scale from
minutes to days. However, it is also apparent from Figure 4B that
models targeted to one level can be used to inform and constrain
models at differing levels. To illustrate this point, the model that
predicts the proportion of weight loss from body fat as a function
of initial fat mass for different degrees of weight loss (Figure 2) [81]
has been used to provide a quantitative constraint on how the
body regulates metabolism of carbohydrate, fat, and protein [61].
This information was useful for the development of a detailed
computational model [78] that simulates the physiological
mechanisms of fuel selection at the whole body level underlying
the regulation of body composition change. The next step requires
adding further mechanistic detail at smaller space–time scales,
such as hormonal regulation of nutrient uptake and utilization
following meals [82]. Such a process demonstrates a logical path
towards generating models with the required level of detail for
nutritional research.
Experimental data has become increasingly available
at the intermediate level between microscopic and
macroscopic. Major sources of new insight in nutritional
sciences are generated on exactly the level missing in the
glucose-insulin example. For example, insights regarding insulin
resistance and the metabolic syndrome have been obtained by
investigating the function of macrophages in specific tissue [83], by
studying the function of adipocytes under various dietary
conditions [84], or by characterizing the effect of tissue-specific
gene knock-outs on metabolic status [85,86]. To integrate these
experimental data, the initial concept should be extended with a
missing fourth model that links gene-specific information from cell
systems with physiological processes on the tissue level; this would
lead to a functional embedding of cellular information.
In our glucose/insulin example we can develop models for both
endogenous glucose production (primarily a liver-based process)
and glucose utilization (dominated by neural tissues and the
musculature) as measured in response to glucose tolerance tests or
glucose-insulin clamps. Details on the molecular mechanisms
underlying the physiological responses of each tissue (derived from
‘‘-omics’’ studies) can then be added. Such efforts could help
explain how a complex organism such as the human reacts to the
dietary stress of, for example, meals with a high glycemic index, or
excess saturated fat. A model at this level would also provide a
platform for linking up with models of how imbalanced nutrition
interacts with processes involved in both metabolic health and
diet-induced disease development.
The need for models that can span levels from cells to tissues,
organs, and organism is further highlighted by the question of how
to translate studies done on humans versus studies done in cell
culture. For example, how would one try to connect the results of a
study using hepatocytes grown on media with very high saturated
fats with a person eating a high saturated fat diet? When one
considers that many experimental results obtained using tissue
cultures are often extrapolated to humans, any study related to
human nutrition requires models that tie the microscopic with the
macroscopic level.
The middle-out design strategy is a promising approach to
generate new multilevel nutritional models. Summarizing the
previous discussion, new multilevel nutritional systems biology models
are needed that should (a) be complete in a space–time dimension sense
and (b) include data and mechanisms to link adjacent levels. For the
development of such models, we propose the ‘‘middle-out’’ design
strategy, that focuses on the level at which the most experimental data
are available, and extends downward as well as upward. Going
downward, it is not necessary to include all possible details in the
model. Indeed, engineering models used to design integrated circuits or
airplanes do not model the condensed matter physics responsible for
the electrical properties of the circuit components. Rather, it is
important to identify the minimum set of players and mechanisms that
are essential to explain the known facts. Going upward, nutritional
models should preferably link to endpoints that can be quantified in
human intervention studies. Here, it is essential to at least include
biomarkers that can play the role of surrogate endpoints. These can
later be linked explicitly with true physiological readouts. Having
experimental data at two or more levels then allows one to build a
mechanistic model that effectively describes the higher aggregation
level as a consequence of the phenomena at the lower level, and is
consistent with all experimental data. In the Virtual Heart model, data
at the cellular level (ion transport) and at the organ level (heart
anatomy) thus provide the means to realistically describe cardiac
arrhythmias. In the PhysioLab platforms, in vitro data on cellular
behavior are synthesized to give an organ level description of, for
example, inflammation, that can then be calibrated against clinical
observations. Ideally, the model design strategy enables the
identification of knowledge gaps: areas where the model is incapable
of bridging between the levels thereby indicating that an essential
player or mechanism has been left out.
Generate phenotypic data to characterize both health and
disease states. In many disease conditions, subphenotypes
have only been poorly recognized. Model building for nutrition
research can only succeed to the extent that phenotypes have been
classified and characterized, especially if one is interested in
understanding transitions between health and disease.
Use the virtual patient concept to deal with variability. One
of the central emerging issues in interpreting experimental data is the
fact that an enormous natural variation occurs between individuals in
any nutritional study. This variability has to be dealt with in nutrition
models. In fact, the variation can be readily simulated by a multilevel
model because one single-model structure can lead to several
physiological outcomes and different phenotypes depending on the
lower level states. The latter may be characterized incompletely, thus
allowing for the variation of experimental data to be adequately
captured by the model. Basically there are two ways of handling this
situation: probabilistic modeling, or a deterministic description of
‘‘virtual patients’’ [76,77]. In the latter, multiple parameterizations of
the model are developed, each corresponding to an observed or
hypothesized individual patient (or patient group). Model simulations
are performed over cohorts of such virtual patients, and the results
(phenotypic readouts) can be matched to experimental observations in
cohorts of real patients, which are frequently only available as cohort
averages.
Use biomarkers to bridge microscopic and macroscopic
levels. In a multilevel nutritional model, going from the lowest
to the highest level in space–time, it does not seem feasible to
retain the full mechanistic detail of the lowest level simply because
data at the (sub) cellular level will generally not be available.
However, we may use the increasingly available ‘‘-omics’’ data to
develop biomarkers, or proxies of what is going on at this lowest
level.
So far, gene and pathway-directed modeling has been
developed in a subcellular to cellular dimension, and kinetic
modeling of intracellular phenomena may become more and more
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level, integrated genomics, proteomics, and metabolomics data
can potentially also be used to bridge between cellular and
physiological states and fill the modeling gap between the
microscopic and the macroscopic levels. One can envision that
through continued and massive experimentation signatures will be
developed that are characteristic of specific pathway perturbations
or disease states. These signatures can give a description of the
state of the transcriptome, proteome, and/or metabolome and
thus link to models developed on this level. The challenge here is
not the modeling (e.g., ‘‘-omics’’ data have been used in
conjunction with pharmacokinetic/pharmacodynamic models
[87]), but rather the choice of experiments. Which model systems
are most representative of the in vivo situation, which systems are
most accessible, and how many signatures can be defined?
Nevertheless, it has been shown that cellular signatures can
indeed be related successfully to ‘‘-omics’’ data obtained in vivo or
ex vivo [88,89], which demonstrates how model systems can be
used in a multilevel approach. On the other hand, the ‘‘-omics’’
signatures are linked to functionally characterized states, such as
the outcome of a drug treatment or a disease on a cellular,
supracellular (e.g., coculture assays as used by the profiling
company Bioseek [90]), or on the organism level. Omics
signatures, for example in the form of biomarker patterns, also
provide a means to characterize virtual patients and virtual patient
cohorts and link with the phenotype at the highest level.
Summary and Conclusion
From this review and discussion it is apparent that two issues in
computational modeling in nutritional sciences now need major
attention. First, the complex biological research questions, typical
for nutritional sciences, often require a multilevel modeling
approach. However, this is a time and resource intensive effort
that is best undertaken within a large research consortium.
Second, a central need exists for models and experimental data
that bridge the microscopic and the macroscopic levels. Most
animal disease models or human nutritional studies currently
provide tissue-specific ‘‘-omics’’ data, whereas cell–cell interaction
data is becoming increasingly available from in vitro systems. To
interpret this new hybrid of wet lab data, dedicated computational
models are required to deal with cell-specific expression data in a
physiological context.
We identified the middle-out strategy as a promising one for
generating the required nutritional computational models and the
virtual patient concept is a convenient way to deal with the large
individual variation typical of nutritional studies. To characterize
(sub) groups of individuals, much will be gained by a careful
classification and characterization of disease (sub) phenotypes.
Finally, the use of biomarker signatures derived from integrated
‘‘-omics’’ data has a potential to bridge the microscopic and
macroscopic levels. In conclusion, we have put available
computational modeling approaches for nutrition into perspective,
and we have suggested the essential elements of an approach for
future fully integrated systems biology models for application in
nutritional sciences.
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